Abstract:BackgroundCardiac troponin I (cTnI) is the preferred biomarker for the diagnosis and management of acute myocardial infarction (AMI). Measurement of high-sensitivity cardiac troponin I (hs-cTnI) is useful for the detection of previously missed minor myocardial injuries, the early diagnosis of acute myocardial infarction, the rational diagnosis of high-risk cardiovascular patients, and for clinical therapeutic decision-making and prognostic assessment. Despite the development of both laboratory-based and point-of-care (POC) cTnI assays, discrepancies in testing results between these platforms underscore the need for highly sensitive assays with commutable results across various clinical settings to enhance patient care.MethodsThis study employed biosensor technology to investigate the interaction between troponin I protein and four commercially available anti-troponin I antibodies (G-129-C, 19C7, Ab01, and Ab02), aiming to optimize assay performance. We evaluated the analytical characteristics of two hs-cTnI assays: YHLO iFlash 3000 for central laboratories and Drawray iStar 500 for POC settings. The limit of blank (LoB), limit of detection (LoD), and limit of quantitation (LoQ) were determined for each assay. A cohort of 650 healthy Chinese individuals (304 males and 346 females) was utilized to establish the 99 th percentile upper reference limits (URLs). Additionally, a Passing-Bablok analysis was conducted on 227 serum samples to assess the concordance between the two methods.ResultsKinetic analysis demonstrated that antibody Ab02 exhibited a 20-fold higher affinity compared to 19C7, while Ab01 displayed approximately a 2-fold higher affinity than G-129-C, despite both pairs recognizing the same troponin I epitope. The imprecision levels for iFlash 3000 and iStar 500 hs-cTnI assays were 3.82% and 3.30%, 2.62% and 3.08%, and 1.88% and 1.82% for low, medium, and high-level controls, respectively. The established LoB and LoD for iFlash 3000 and iStar 500 hs-cTnI assays were 0.12 ng/L and 0.22 ng/L, and 0.37 ng/L and 0.44 ng/L, respectively. The correlation between Drawray iStar 500 and YHLO iFlash 3000 assay results was robust (r= 0.9993) across a wide range of troponin I concentrations (0.12 - 39600 ng/L), with measurable concentrations above 50% (83.54%, 87.83%, and 79.77%) for the overall, male, and female cohort. The non-parametric 99 th percentile URL of iFlash 3000 hs-cTnI in the study cohort was 9.94 ng/L (90%CI 8.23-13.64 ng/L), with gender-specific variations observed. The coefficient of variation (%CV) at the 99 th percentile value was well below 10% for the overall, male, and female cohort (3.42%, 2.82%, and 3.64%).ConclusionsThe findings affirm that both iFlash 3000 and iStar 500 hs-cTnI assays meet the criteria for high sensitivity and exhibit a strong correlation in test results. This correlation suggests their potential for interchangeable use in diverse clinical settings, thereby enhancing patient management. The distinct gender-specific 99 th percentile URLs underscore the importance of tailored reference values in clinical assessments. The high precision and low limits of detection and quantitation further validate the reliability of these assays in the early diagnosis and management of AMI patients.

Determination of Age- and Sex-Specific 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin I in Healthy Chinese Adults

Ethnicity and sex-specific 99th percentile upper reference limits of high-sensitivity cardiac troponin I among adults in Xinjiang, China

Reference Intervals For Plasma Pro-Gastrin Releasing Peptide (Progrp) Levels In Healthy Adults Of Chinese Han Ethnicity

Specific reference interval for high-sensitivity cardiac troponin I among healthy children in Wuhan, China

Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay

Age‐Specific 99th Percentile Cutoff of High‐Sensitivity Cardiac Troponin T for Early Prediction of Non‐ST‐Segment Elevation Myocardial Infarction (NSTEMI) in Middle‐Aged Patients

Age- and sex-specific upper reference limits for cardiac biomarkers in Chinese children and adolescents: a prospective study

Age-Sex Distribution Of Patients With High-Sensitivity Troponin T Levels Below The 99th Percentile

High-sensitivity Cardiac Troponin T in Geriatric Inpatients.

Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives

The Analytical Performance Assessment of High-Sensitivity Cardiac Troponin T Reference Intervals Investigation

Data Mining: Biological and Temporal Factors Associated with Blood Cardiac Troponin I Concentration in a Chinese Population.

Establishment of high-sensitivity cardiac troponin I reference interval for a hospitalized paediatric population under improved selection criteria in the Shandong area

Age and Gender Tailored Cutoff Value of Hs-Ctnt Contributes to Rapidly Diagnose Acute Myocardial Infarction in Chest Pain Patients

A population model of age and gender specific cardiac troponin levels

A-336 Comparative Evaluation of Homogeneous Point-of-Care and Central Laboratory Chemiluminescent Immunoassays for High-Sensitivity Cardiac Troponin I

A-002 Analytical Validation of the Zybio High Sensitivity Cardiac Troponin I CLIA Assay

The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications

Evaluation of Age and Sex Differences in Contemporary versus High-Sensitivity Troponin I Measurement in Hospitalized Patients

Evaluation of the Analytical and Clinical Performance of a New High-Sensitivity Cardiac Troponin I Assay: Hs-Ctni (CLIA) Assay.

A Multicenter Reference Intervals Study for Specific Proteins in China